TMLHE pseudogene 1 (TMLHEP1)

TMLHE pseudogene 1 (TMLHEP1) is a pseudogene related to the Trimethyllysine dioxygenase, mitochondrial (TMLHE) gene. Pseudogenes are segments of DNA that resemble functional genes but typically have lost their original coding potential due to mutations, deletions, or insertions and thus do not produce a functional protein. In humans, the functional TMLHE gene encodes Trimethyllysine dioxygenase, mitochondrial, the enzyme catalyzing the first step in carnitine biosynthesis, which is biologically and clinically relevant[3][4][5]. The presence of a TMLHE pseudogene is noted in genomic databases[4], but by definition, pseudogenes are neither therapeutic targets nor do they have molecular, biological, or disease functions unless re-functionalized, which there is no evidence for in this case. In genetic studies, pseudogene interference can complicate molecular assays targeting the bona fide TMLHE gene, necessitating careful primer design[1]. TMLHEP1 is not an enzyme, receptor, transporter, or therapeutic target. It is a pseudogene and not considered biologically functional or pharmacologically relevant. There is no evidence of TMLHEP1 involvement in disease, biomarker potential, drug targeting, or therapeutic challenges.

Other names

TMLHEPTMLHE pseudogene